Walleye Capital’s Japer Therapeutics Warrants JSPRW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-200,000
Closed -$2.7K – 6074
2026
Q2
$2.7K Hold
200,000
– – ﹤0.01% 4576
2026
Q1
$4.38K Hold
200,000
– – ﹤0.01% 4207
2025
Q4
$8.02K Sell
200,000
-360,061
-64% -$40.6K ﹤0.01% 4309
2025
Q3
$44.6K Hold
560,061
– – ﹤0.01% 4037
2025
Q2
$70K Hold
560,061
– – ﹤0.01% 3925
2025
Q1
$80.1K Sell
560,061
-13,579
-2% -$2.14K ﹤0.01% 3700
2024
Q4
$120K Sell
573,640
-22,374
-4% -$4.7K ﹤0.01% 4049
2024
Q3
$119K Hold
596,014
– – ﹤0.01% 4320
2024
Q2
$119K Hold
596,014
– – ﹤0.01% 4634
2024
Q1
$108K Sell
596,014
-99,000
-14% -$15.7K ﹤0.01% 4352
2023
Q4
$55.6K Sell
695,014
-5,422
-0.8% -$450 ﹤0.01% 4268
2023
Q3
$35K Sell
700,436
-301
-0% -$26 ﹤0.01% 4277
2023
Q2
$98.2K Buy
700,737
+45,903
+7% +$7.07K ﹤0.01% 3444
2023
Q1
$131K Buy
654,834
+629,775
+2,513% +$91.9K ﹤0.01% 2780
2022
Q4
$752 Hold
25,059
– – ﹤0.01% 3072
2022
Q3
$2K Hold
25,059
– – ﹤0.01% 3060
2022
Q2
$2K Hold
25,059
– – ﹤0.01% 2249
2022
Q1
$7K Hold
25,059
– – ﹤0.01% 2155
2021
Q4
$37K Sell
25,059
-55,625
-69% -$77.5K ﹤0.01% 1817
2021
Q3
$119K Buy
+80,684
New +$86.3K ﹤0.01% 1294
2021
Q1
– Sell
-33,410
Closed -$48K – 1258
2020
Q4
$48K Sell
33,410
-17,790
-35% -$22.3K ﹤0.01% 874
2020
Q3
$57K Buy
+51,200
New +$51.8K 0.01% 751

Walleye Capital's JSPRW Position: Q3 2026 in Review

Walleye Capital sold out of Japer Therapeutics Warrants (JSPRW) in Q3 2026, closing a stake of 200,000 shares — an estimated $2.7K sold.

Walleye Capital first reported a position in JSPRW in Q3 2020 and held it in 22 quarters. The position peaked at $131K in Q1 2023. 1 fund tracked by Wall St. Rank holds JSPRW as of Q3 2026.

  • Walleye Capital reported no remaining Japer Therapeutics Warrants position as of Q3 2026 after selling out during the quarter.
  • Walleye Capital sold 200,000 Japer Therapeutics Warrants shares in Q3 2026, an estimated $2.7K.
  • Walleye Capital first reported a position in Japer Therapeutics Warrants in Q3 2020 and held it in 22 quarters.
  • Walleye Capital's Japer Therapeutics Warrants position peaked at $131K in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Japer Therapeutics Warrants as of Q3 2026.

Based on Walleye Capital's 13F filing for Q3 2026, filed 13 Nov 2026.